0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Reduced Tumor Necrosis Factor α Production in Lipopolysaccharide-Treated Whole Blood From Patients in the Intensive Care Unit

John C. Setrakian, MD; John Yee, MD; Nicolas V. Christou, MD, PhD
Arch Surg. 1994;129(2):187-192. doi:10.1001/archsurg.1994.01420260083011.
Text Size: A A A
Published online

Objective:  To determine the cytokine response to lipopolysaccharide in patients in the intensive care unit.

Patients:  Patients in a mixed medical/surgical intensive care unit with fever and a de novo clinical dysfunction of at least one organ system.

Methods:  Whole blood from patients and from laboratory controls was stimulated with 8 ng/mL of lipopolysaccharide (Escherichia coli 0111:B4) at 37°C, and tumor necrosis factor α (TNF-α) was measured using enzyme linked immunosorbent assay at 4,8, and 24 hours. The same subjects' purified monocytes were cultured with 8 ng/mL of lipopolysaccharide in the presence of autologous or pooled control plasma or cocultured with purified autologous polymorphonuclear leukocytes at a polymorphonuclear leukocyte—monocyte ratio of 10:1, and TNF-α was measured at 24 hours using the enzyme linked immunosorbent assay.

Results:  We detected high (n=5) and low (n=5) TNF-α responders in whole blood producing a mean (±SEM) of 27.2± 6.3 pg/mL per 1000 monocytes vs 0.0±2.4 pg/mL per 1000 monocytes, respectively (controls, 58.0±13.0 pg/mL per 1000 monocytes). The kinetics of TNF-α production in both groups were comparable. Purified monocytes from both groups of patients cultured with lipopolysaccharide alone produced equivalent TNF-α values (42.4±10.5 vs 40.8± 12.5 pg/mL per 1000 monocytes). Assayable TNF-α was not different with autologous vs control serum but was markedly diminished by the presence of polymorphonuclear leukocytes in patients as well as in controls; the two groups of patients did not differ in this polymorphonuclear leukocyte effect.

Conclusion:  Lipopolysaccharide stimulation of monocytes in the whole blood results in marked variation of TNF-α production. This phenomenon may account for the variable septic response to infection in patients in the intensive care unit.(Arch Surg. 1994;129:187-192)

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();